Skip to main content
Sunil Badve, MD, Pathology, Atlanta, GA

SunilBadveMD

Pathology Atlanta, GA

Molecular Genetics, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor and Vice Chair, Pathology Cancer Program Department of Pathology and Laboratory Medicine Emory University School of Medicine

Dr. Badve is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Badve's full profile

Already have an account?

  • Office

    1364 Clifton Road NE, Room H184
    Atlanta, GA 30322
    Phone+1 404-712-8579

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1998
  • Grant Medical College
    Grant Medical CollegeClass of 1986

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2021 - 2026
  • IN State Medical License
    IN State Medical License 2002 - 2021
  • IL State Medical License
    IL State Medical License 1999 - 2002
  • NY State Medical License
    NY State Medical License 1999 - 2000
  • CT State Medical License
    CT State Medical License 1998 - 1999
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  
    Matthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine

Press Mentions

  • Managing Central Nervous System Metastasis in Patients with HER2-Positive Breast Cancer
    Managing Central Nervous System Metastasis in Patients with HER2-Positive Breast CancerOctober 22nd, 2024
  • Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer Patients
    Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer PatientsJune 22nd, 2022
  • Chronic Kidney Disease Medication Doesn’t Work, Shows Study
    Chronic Kidney Disease Medication Doesn’t Work, Shows StudyJune 28th, 2020
  • Join now to see all

Professional Memberships